1-14 of 14
Michael Keng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Outcomes with Hypomethylating Agents and Venetoclax for AML in the Community Compared to an Academic Setting

Jeffrey Lantz, Jr., Natalie Pham, Caroline Jones, Debamita Kundu, Nicholas McCann, Firas El Chaer, Daniel Reed, Michael Keng
Journal: Blood
Blood (2023) 142 (Supplement 1): 7436.
https://doi.org/10.1182/blood-2023-190176
Published: 2023
Journal Articles

Frontline Aspacytarabine with Venetoclax for Older/Unfit Patients with Acute Myeloid Leukemia: Preliminary Results of a Phase 1 Study

Jessica K. Altman, Yasmin Abaza, Michael Keng, Abhishek Maiti, Jamie Koprivnikar, Shoshi Tessler, Chen Blumberg, Liat Flaishon, Ruth Ben Yakar
Journal: Blood
Blood (2023) 142 (Supplement 1): 5970.
https://doi.org/10.1182/blood-2023-185694
Published: 2023
Journal Articles

A Phase 2 Study of Lenalidomide in Combination with Mitoxantrone, Etoposide, and Cytarabine (Len plus MEC) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Manik Razdan Kuchroo, Robert A. Redd, Jacqueline S. Garcia, Michael Keng, Gabriela S. Hobbs, Jacalyn Rosenblatt, Marlise R. Luskin, Rupa Narayan, Philip C. Amrein, Malgorzata McMasters, Martha Wadleigh, Hanno Hock, Richard Stone, Donna S. Neuberg, David Avigan, Karen K. Ballen, Amir T. Fathi, Daniel J. DeAngelo, Andrew M. Brunner
Journal: Blood
Blood (2023) 142 (Supplement 1): 2894.
https://doi.org/10.1182/blood-2023-188182
Published: 2023
Journal Articles

Ongoing Phase III Randomized Trial of Salvage DFP-10917 Vs. Non-Intensive Reinduction or Intensive Reinduction for Acute Myelogenous Leukemia (AML)

Timothy Pardee, Michael Keng, Kiyoshi Eshima, Kenzo Iizuka, Chun Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5976.
https://doi.org/10.1182/blood-2023-190476
Published: 2023
Journal Articles

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Clinical Trials & Observations
Jacqueline S. Garcia, Yael Flamand, Livius Penter, Michael Keng, Benjamin K. Tomlinson, Lourdes M. Mendez, Paul Koller, Nicole Cullen, Yohei Arihara, Kathleen Pfaff, Jacquelyn O. Wolff, Andrew M. Brunner, Ilene Galinsky, Asad Bashey, Joseph H. Antin, Corey Cutler, Vincent Ho, Brian A. Jonas, Marlise R. Luskin, Martha Wadleigh, Eric S. Winer, Alexandra Savell, Rebecca Leonard, Taylor Robertson, Matthew S. Davids, Howard Streicher, Scott J. Rodig, Jerome Ritz, Catherine J. Wu, Daniel J. DeAngelo, Donna Neuberg, Richard M. Stone, Robert J. Soiffer
Journal: Blood
Blood (2023) 141 (15): 1884–1888.
https://doi.org/10.1182/blood.2022017686
Published: 2023
Includes: Supplemental data
Journal Articles

Aspacytarabine (BST-236) As Monotherapy Is Safe, Well-Tolerated and Effective for the Treatment of Adults with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Therapy. Results of a Phase 2 Study

Jessica K. Altman, Jamie Koprivnikar, James K McCloskey, Vamsi Kota, Michael Keng, Dale L. Bixby, Olga Frankfurt, Ashkan Emadi, Tsila Zuckerman, Micah M. Burch, Moshe Y. Levy, Selina M. Luger, Bhavana Bhatnagar, Ofir Wolach, Chezi Ganzel, Mary-Beth M. Percival, Gail J. Roboz, Michael Craig, Itai Levi, Anna Gourevitch, Liat Flaishon, Darrel P. Cohen, Shoshi Tessler, Chen Blumberg, Stela Gengrinovitch, Ruth Ben Yakar, Jacob M. Rowe
Journal: Blood
Blood (2021) 138 (Supplement 1): 1273.
https://doi.org/10.1182/blood-2021-149361
Published: 2021
Journal Articles

Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve Settings

Jacqueline S. Garcia, MD, Yael Flamand, MS, Benjamin K. Tomlinson, MD, Michael Keng, MD, Lourdes M. Mendez, MD PhD, Samer Khaled, MD, Asad Bashey, MD PhD, Andrew M. Brunner, MD, Alexandra Savell, BS, Donna Neuberg, Ilene Galinsky, Marlise R. Luskin, MD, David P. Steensma, MD, Martha Wadleigh, MD, Eric S. Winer, MD, David E. Avigan, MD, Nicole Cullen, Scott Rodig, MD PhD, Livius Penter, R. Coleman Lindsley, MD PhD, Stephanie Andrews, Matthew S. Davids, MD, Catherine J. Wu, MD, Richard M. Stone, MD, Daniel J. DeAngelo, MD PhD, Robert J. Soiffer, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–17.
https://doi.org/10.1182/blood-2020-136235
Published: 2020
Journal Articles

Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Naïve Patients with Relapsed or Refractory Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Multi-Center Phase 1, Two-Arm, Dose-Escalation Study

Jacqueline S Garcia, MD, Lillian Werner, Benjamin K. Tomlinson, MD, Michael Keng, MD, Myrna Nahas, MD, Andrew Brunner, MD, Samer K. Khaled, MD, Alexandra Savell, BS, Marlise Luskin, MDMS, David P. Steensma, MD, Martha Wadleigh, MD, Eric S. Winer, MD, Edwin P. Alyea, III, MD, Corey Cutler, MD MPH, FRCPC, Vincent T. Ho, MD, Donna S Neuberg, ScD, Nicole Cullen, Andreas Kantartzis, Ana Lako, Scott Rodig, MD PhD, R. Coleman Lindsley, MD PhD, Yael Flamand, Claire Manuszak, Ryan Brennick, Mariano Severgnini, Stephanie Andrews, Ilene Galinsky, Pavan Bachireddy, MD, Yohei Arihara, MD PhD, Jerome Ritz, MD, Matthew S. Davids, MD, Howard Streicher, MD, Catherine J. Wu, MD, Richard M. Stone, MD, Daniel J. DeAngelo, MD, Robert J. Soiffer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2015.
https://doi.org/10.1182/blood-2019-126238
Published: 2019
Journal Articles

A Multidisciplinary Effort to Decrease Time from Admission to Chemotherapy on an Inpatient Oncology Unit

Louise Man, MD, Jeremy Sen, PharmD, BCOP, Jeanne Cahan, BSN, RN, Kathlene DeGregory, PharmD, BCOP, Tanya Thomas, BSN, RN, OCN, Elizabeth Daniels, RN, MSN, Erin McLoughlin, MD, Amy Morris, PharmD, Lisa Huntsinger, RN, MSN, CCRN, Michael Keng, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2129.
https://doi.org/10.1182/blood.V130.Suppl_1.2129.2129
Published: 2017
Journal Articles

Prospective Study of an Antifungal Program to Reduce Invasive Fungal Infections in Patients with Acute Myeloid Leukemia Receiving Induction and Re-Induction Chemotherapy

Amy Morris, PharmD, Mohammed Athar Naeem, MDPhD, Anjali Bal, MD, Torey Murray, RN, Tanya Thomas, BSN, RN, OCN, Kathlene DeGregory, PharmD, BCOP, Jessica Lewis, MD, Michael Keng, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 345.
https://doi.org/10.1182/blood.V130.Suppl_1.345.345
Published: 2017
Journal Articles

Ethnic Disparities in Multiple Myeloma: A Comparative Analysis of Hispanic Patients.

Michael Keng, MD, Asher A. Chanan-Khan, MD, Eddie Thara, MD, Dongyun Yang, PhD, Ann Mohrbacher, MD, Susan Groshen, PhD, Sikander Ailawadhi, MD
Journal: Blood
Blood (2009) 114 (22): 4875.
https://doi.org/10.1182/blood.V114.22.4875.4875
Published: 2009
Journal Articles

Geographical Variation Shows Differences in Disease Characteristics Among Patients with Multiple Myeloma.

Sikander Ailawadhi, MD, Michael Keng, MD, Ann Mohrbacher, MD, Eddie Thara, MD, Dongyun Yang, PhD, Taimur Sher, MD, Mehul P Patel, MB, BS, Kena C Miller, NP, Susan Groshen, PhD, Asher A. Chanan-Khan, MD
Journal: Blood
Blood (2009) 114 (22): 4895.
https://doi.org/10.1182/blood.V114.22.4895.4895
Published: 2009
Journal Articles

High-Dose Cyclophosphamide: An Effective Non-Transplant Salvage Option in Relapsed/Refractory Multiple Myeloma.

Sikander Ailawadhi, MD, Michael Keng, MD, Eddie Thara, MD, Andrew Hendifar, Tanya Price, RN, Lisa Hanna, RN, MSN, Lisa Mark, PA, Ann Mohrbacher, MD
Journal: Blood
Blood (2009) 114 (22): 4947.
https://doi.org/10.1182/blood.V114.22.4947.4947
Published: 2009
Journal Articles

Thyroid Disorder-Related Immune Thrombocytopenia: Clinical and Laboratory Characteristics

Eric M. Cheung, DO, Rahul Naik, MD, Michael Keng, MD, Howard A. Liebman, MA, MD
Journal: Blood
Blood (2008) 112 (11): 4561.
https://doi.org/10.1182/blood.V112.11.4561.4561
Published: 2008